Appeal 2006-3252
Application 09/536,728
H
H Br
N
H N
N
N CH3 H
1 H3C CH3
2
3 Formula 3
4
5 A method for making the compound is described in Esser Example 2.
6 Publication, ¶¶ 0106 through 0108.
7 A comparison of the compound of Esser Example 2 with
8 phenylephrine for treatment of urinary incontinence is described in Table 1.
9 Publication, ¶¶ 0137 through 0139.
10
11 Claims under consideration
12 Claims 26 and 73-81 are before us.
13 We refer the reader to Appendix 1 for a copy of the claims, as well as
14 non-involved claim 21 from which some claims before us depend.
15
16 Olson
17 Olson, owned by Merck & Co., Inc., relates to "novel" compounds
18 and a method of using the compounds to delay the onset of egg production
19 in young pullets and interrupting the egg production of mature laying hens
20 by administration of one or more of the compounds—usually in a feed mix.
21 Col. 1:6-21.
10
Page: Previous 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next
Last modified: September 9, 2013